Pivotal Clinical ApS: Financial statements 2024
CVR: 40343040
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pivotal Clinical ApS (CVR 40343040) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -25 and a net result of DKK -32 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 49,968. The solvency ratio was 100%.
- Gross Profit
- DKK -25
- Profit/Loss
- DKK -32
- Equity
- DKK 49,968
- Total Assets
- DKK 49,968
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -25 | -32 | 50K | 0 |
| 2023 | - | - | 0 | 50K | 0 |
| 2022 | - | - | 366 | 50K | - |
| 2021 | - | - | -366 | 50K | - |
| 2020 | - | - | 0 | 50K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pivotal Clinical ApS has published its annual report for 2023. The net result was DKK 0.
About Pivotal Clinical ApS
Pivotal Clinical ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ibrahim Naman Farr Juri. The company is owned by Pivotal S.L.. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -75 and a net result of DKK -82 compared with DKK -32 the year before. Equity in the 2025 report amounted to DKK 49,886.
